Results 131 to 140 of about 30,536 (239)

Analysis of Patients With Monocytic and Monocytic‐Like Acute Myeloid Leukemia, Including AML‐M4 and AML‐M5, Treated With Venetoclax Plus Azacitidine

open access: yes
American Journal of Hematology, Volume 101, Issue 3, Page 577-580, March 2026.
Marina Konopleva   +8 more
wiley   +1 more source

Physicochemical Stability of Reconstituted Decitabine (Dacogen®) Solutions and Ready-to-Administer Infusion Bags when Stored Refrigerated or Frozen

open access: yesPharmaceutical Technology in Hospital Pharmacy, 2017
Profound knowledge about the physicochemical stability is necessary in order to determine the “beyond-use-dates” of ready-to-administer preparations after reconstitution and dilution.
Kim Sun Hee   +2 more
doaj   +1 more source

Understanding drugs in breast cancer through drug sensitivity screening [PDF]

open access: yes, 2015
With substantial numbers of breast tumors showing or acquiring treatment resistance, it is of utmost importance to develop new agents for the treatment of the disease, to know their effectiveness against breast cancer and to understand their ...
Foekens, J.A. (John)   +8 more
core   +4 more sources

Comparison of clinical efficacy between decitabine combined with half the amount of CAG regimen with CAG regimen alone in patients with inermediate to high-risk myelodysplastic syndrome

open access: yesBIO Web of Conferences, 2017
Objective: To investigate the efficacy and safety of decitabine combined with half the amount of CAG and CAG regimen alone. Methods: Comparison the effectiveness, overall survival and incidence of adverse reactions of 42 cases of MDS used decitabine ...
Fan Zhenwei   +4 more
doaj   +1 more source

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

open access: yesSystematic Reviews, 2018
Background Hypomethylating agents (HMA), azacitidine, and decitabine are frequently used in the management of myelodysplastic syndromes (MDS). However, there are no clinical trials that have directly compared these agents.
Jehad Almasri   +7 more
doaj   +1 more source

Effects of post-transplant maintenance therapy with decitabine prophylaxis on the relapse for acute lymphoblastic leukemia

open access: yesBone Marrow Transplantation, 2023
Jixin Fan   +14 more
semanticscholar   +1 more source

Decitabine and trichostatin A : a synergistic combination in ALL [PDF]

open access: yes, 2009
Dissertação de mestrado integrado em Medicina, apresentado á Faculdade de Medicina da Universidade de CoimbraInvestigações recentes demonstraram que a regulação epigenética da expressão génica envolve a metilação regiões CpG, assim como a desacetilação ...
Costa, Carlos
core  

A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation

open access: yesScientific Reports
The search for new approaches in cancer therapy requires a mechanistic understanding of cancer vulnerabilities and anti-cancer drug mechanisms of action.
Alex Y. Ge   +14 more
doaj   +1 more source

Serendipity: Decitabine monotherapy induced complete molecular response in a 77-year-old patient with acute promyelocytic leukemia [PDF]

open access: yes, 2019
Abboud, Camille N   +7 more
core   +3 more sources

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen [PDF]

open access: yes, 2017
Abboud, Camille N   +18 more
core   +2 more sources

Home - About - Disclaimer - Privacy